Paderborner Straße 44
33181 Bad Wünnenberg, de
+49 (69) 743037-00
Biogas Nord AG: Information to financial results 2012
- Disclosure of 2012 annual report postponed to the end of July 2013 because of conversion to IFRS
- Order backlog as of 31. December 2012 of EUR 37 million (98 percent abroad)
- Globalization strategy continues to be successful / Global sales 2012 up by more than 300 % from EUR 8.8 million to EUR 36 million
- Outlook 2013: Strong international growth with positive net results /additional orders of EUR 31 million received during 2013
Biogas Nord AG, one of the leading providers of innovative and customized energy solutions in the field of Biogas technology, publishes first information on the preceding financial year 2012.
Without giving detailed preliminary figures, the overall performance of 2012 was lower than in the fiscal year 2011. The market for the construction of new biogas plants in Germany was clearly behind the already low expectations forecast by the German Biogas Association. Thus in 2012 the revenues from sales in Germany of Biogas Nord AG clearly decreased. Despite the decline of the German biogas industry by nearly 74 percent, the company was able to partly compensate for the decline in sales revenue from Germany with contributions from international business. During the year 2011, the sales revenues that were generated abroad have been EUR 8,8 million (12 % of the total sales), and during 2012 the revenues from abroad increased by more than 300 % to EUR 36 million.
Biogas Nord AG is consequently working on its globalization strategy. During 2012 the company has increased its international presence to 14 countries in total, and in 2013 we started additional activities in two more countries. Those activities also are reflected in our current order backlog of EUR 68 million (June 2012: EUR 36 million).
The 2012 annual report of Biogas Nord AG is drawn up for the first time in accordance with the International Financial Reporting Standards (IFRS). Because of the changes in the accounting method, the expected release of the financial results will be postponed to the end of July 2013. The Deutsche Börse AG has been informed about of this fact.
"Within a short time, through the global expansion of Biogas Nord, we were able to compensate for the drop in the sales of biogas plants in Germany. We recognized already in 2011 that the future of the company is primarily focused on the expansion of its international business, as well as on the implementation of innovative and technically advanced power solutions. In the face of the strong order backlog and due to our extremely intense efforts in recent years to reshape Biogas Nord AG so as to become a global player, in 2013 we expect an increase of revenues, a positive result and considerable company growth for the following years." said Alexander Rechter, CEO of Biogas Nord AG.
This Corporate News is intended solely for informational purposes and does not constitute a solicitation to buy, hold or sell securities. This Corporate News may contain forward‐looking statements. Forward‐looking statements are statements that are not historical facts. They include statements about our beliefs and expectations. These statements relate to the current plans, estimates and forecasts currently available to the BIOGAS NORD AG management. Forward‐looking statements therefore only apply on the day they were made. By their nature, forward‐looking statements harbor risks and possible uncertainties. Various known and unknown risks, uncertainties and other factors could mean that the actual results, the financial situation, the development or the performance of the company greatly differs from the estimations published here. These factors include those described by BIOGAS NORD AG in its published reports. These reports are available on the BIOGAS NORD website at www.biogas‐nord.com. We assume no liability whatsoever to update these forward‐looking statements or to adjust them in line with future events or developments.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.